RxDoctor Payments Data

Manda Maley, MD

Vascular Surgery · Lexington, KYNPI 1346744869

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (60.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Silk Road Medical, Inc. at 29.4% of the total. Reporting peaked in 2024 at $2,773 and has fallen 87.8% since, to $338 in 2025. That places this record below the midpoint for vascular surgery clinicians in KY, where the typical reported total is $9,151.

$6,516in general payments, 2019–2025

Across 52 payments — averaging $125.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Silk Road Medical, Inc.$2K
  • Cardiovascular Systems Inc.$1K
  • Philips North America LLC$878
  • W. L. Gore & Associates, Inc.$650
  • Boston Scientific$601
  • Medtronic$601
  • plus $451 from 4 others

What the payments were for

  • Travel & lodging$2,08432%
  • Food & beverage$3,90960%
  • Education$5238%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,516 in reported general payments places this provider in the 40th percentile of 72 vascular surgery providers in Kentucky.

See all vascular surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$40,330
Medicare patients
243
Services billed
384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban30$18,094
Cilostazol13$178
ClopidogrelClopidogrel Bisulfate33$168
Rosuvastatin Calcium15$44

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →